Authors


Jennifer Markarian

Latest:

Exploring 3D Printing for Solid Dosage Drugs

As a GMP manufacturing method, 3D printing offers benefits for modified release and personalized dosages.



Johan Remmelgas

Latest:

Predicting Moisture Uptake in Solid Dosage Packaging

Moisture uptake during the end-to-end manufacturing process and supply chain can affect product quality. Simulation tools based on mechanistic models help define storage and handling requirements for oral solid-dosage drugs.


Philippe Adam

Latest:

Best Practices: How to Avoid the Five Common Pharma Packaging and Labelling Artwork Hurdles

This article looks at five of the most common hurdles in packaging and labelling artwork and how to avoid them.


Anne Hansen

Latest:

Evaluating Mixing in a Single-Use Bioprocessing System

Quantitative and qualitative tools allow better understanding of mixing in a single-use bioprocessing system.


Martin Köberle

Latest:

From Bitter to Sweet: Developing a User-Friendly Painkiller

Hot-melt coating was used to develop taste-masked orally disintegrating granules of acetaminophen and caffeine.


Detlev Haack

Latest:

From Bitter to Sweet: Developing a User-Friendly Painkiller

Hot-melt coating was used to develop taste-masked orally disintegrating granules of acetaminophen and caffeine.


Cherie Schneider

Latest:

Overcoming Low Endotoxin Recovery

Understanding of endotoxin assays and a range of detection technologies are essential for effective testing.


Merck

Latest:

Enhancing API Solubility During API Processing and Formulation Development Merck

Understanding the impact of API solubility on the performance of a given drug product and determining ways to enhance dissolution rates is critical to ensuring your product makes it to market, into the hands of patients and clinicians, is well absorbed and provides its intended therapeutic effect. Selecting the best formulation strategy to address challenges for each API, however, can be time-consuming, costly and complex.


Randi Hernandez

Latest:

GE Healthcare: The Next Cell and Gene Therapy Manufacturing Giant?

GE Healthcare continues to ramp up its offerings in the bioprocessing space with the purchase of Asymptote and a continued partnership with Zenith Technologies.


Randi Hernandez

Latest:

Boosting Bioproduction Workflows with Automation Technologies

As cost pressures mount as a result of multiple biologics being developed for the same indication, manufacturers can harness process efficiencies to maintain the value of legacy products.


Jim Miller

Latest:

What Ifs in the Five-Year Plan

Heightened uncertainty means CDMO executives need to play out planning scenarios.


Jim Miller

Latest:

CMOs Face a Kodak Moment

The evolving bio/pharmaceutical business model poses risk for CMOs.


Sean Milmo

Latest:

Adapting Regulations Post-Brexit

The UK government is taking advantage of the new regulatory flexibility, afforded by Brexit, to boost the country’s competitiveness in pharma.


Sean Milmo

Latest:

Business on Hold? EMA’s Full Recovery in Question

EMA is facing a dilemma in trying to restore activities back to normal after relocating and the COVID-19 pandemic.


Jill Wechsler

Latest:

Signing Off from Washington

FDA and industry face unprecedented political and policy challenges.


Jill Wechsler

Latest:

FDA Highlights Value and Challenges of Advanced Drug Manufacturing

FDA is expanding its Emerging Technology Program and providing more support for new drug applications that present advanced manufacturing technologies.


Jill Wechsler

Latest:

Uniformity of Bioprocessing Equipment Manufacturing

The American Society of Mechanical Engineers' Council on Codes and Standards established an ad hoc committee to examine whether a standard to create uniformity and consistency in the bioprocessing industry is needed. This article describes the goals and current activities of the standards committee and its subcommittees.


Stephen M. Perry

Latest:

Elasticity – A Modern Paradigm for a High Performance Workforce

Top C-suite leaders are already tuning their long-range planning, hiring practices, and business systems for elasticity. Are you ready?


Dijana Hadziselimovic

Latest:

Considerations for Cleaning Lipid Nanoparticles

This article explores the concerns with cleaning pharmaceutical products utilizing LNP delivery vehicles and provides a general cleaning recommendation based on laboratory and field testing.


Marc Hogreve

Latest:

Point-of-Use Leak Testing of Single-Use Bag Assemblies

The authors describe the development and validation of a highly sensitive point-of-use pressure decay test.


Siegfried Schmitt

Latest:

Complying with European versus US GMPs

While global harmonization exists, there are still differences between the US and European GMP requirements that manufacturers should know, says Siegfried Schmitt, PhD, vice president, Technical at Parexel.


Natalia Markova

Latest:

Shining a Light on Lipid Nanoparticle Characterization

Using an orthogonal approach to lipid nanoparticle analysis can increase the odds of project success.


Christian Fortunel

Latest:

The Transition to Electronic Records

A four-stage process to successfully make the switch from paper to electronic batch records is presented.


Ashleigh Wake

Latest:

Characterization and Impurity Analysis of Oligonucleotide Therapeutics

Analytical technologies play a key role in the characterization and quantitation of oligonucleotide therapeutics.


Niels Væver Hartvig

Latest:

Understanding Internal Release Limits

Internal release limits help ensure that a batch of drug product remains within specifications throughout its shelf life. This article explores what internal release limits are and why they are important.


Liselotte Kamper

Latest:

A Statistical Decision System for Out-of-Trend Evaluation

The authors present a set of statistical decision rules based on linear regression models that can be implemented in an automated trend system to assist stability studies.


SCHOTT AG

Latest:

SCHOTT Vials DC Demonstrate Resistance against Delamination in New Screening Study

A new series of studies has demonstrated the effectiveness of SCHOTT Vials Delamination Controlled (DC), which can replace existing packaging solutions without re-registration and offers higher product security.


Catherine Shaffer

Latest:

Ensuring the Biological Integrity of Raw Materials

A multi-pronged approach to raw materials testing can help mitigate the risk of future contamination events.


Johanna Berberich

Latest:

The GMP/GDP Inspections Landscape—Part II: Considerations and Opportunities

The authors look at challenges and considerations to continuously improve inspection efficiency.